Current News

Contact | Print version | PDF version | Send article | RSS-Feed

Quest PharmaTech Signs Agreement to sell Bionex Technology

13 May 2008 - Quest PharmaTech Inc. announced that it has signed a Technology Transfer Agreement with Peking Marvel Cleansing Supplies Co., Ltd., a China-based company, to sell its interest in the Bionex Technology. Peking Marvel is anticipated to be acquired by a TSX NEX listed company called Toba Industries Ltd (TGB-H).
 
Under the terms of the Agreement, Quest will receive $50,000 in cash and 1,351,111 common shares of Toba Industries Ltd. In addition, Quest will also receive $200,000 in the form of future royalties upon successful commercialization of Bionex related products by Peking Marvel. The Agreement is contingent upon TSX Venture Exchange approval of the pending transaction between Peking Marvel and Toba Industries Ltd.
 
The Bionex Technology comprises a family of novel disinfectants used for multiple applications including hard surface and hand gel disinfectants. Patents have been granted for part of the Technology in USA, Europe and China. The sale of Bionex completes the divesture of non-core products and programs initiated by Quest in 2005.